Search PACB
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Nasdaq · CIK 1299130
Last close2.54
Daily change+0.03 (1.20%)
10 Years gain-71.49%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
PACB · STANDARD
SIC 3826 · Laboratory Analytical Instruments · Fiscal year end 1231
Fundamental
45.1Momentum
100.0Acceleration
100.0Confidence
85.0Annual Revenue10
Quarterly Revenue62
Annual CFO15
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth0.9 / 25
Quality12.5 / 25
Capital Efficiency15.3 / 20
Balance Sheet15.0 / 15
Shareholder Economics0.0 / 10
Forward Indicators1.5 / 5
Signals
Gross margin expansionGross margin improved by 19.2978 percentage points.
Operating leverageOperating margin improved by 405.2114 percentage points.
Key Metrics
Revenue Growth TTM1.61%OK
Revenue CAGR 3Y-5.37%OK
Gross Margin36.31%OK
Operating Margin-88.54%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROICn/aMISSING
Incremental Operating Margin 3Y596.61%OK
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y4.65%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | n/a | $45.78M | -$553.86M | -$111.21M | -$113.92M | n/a | n/a | n/a | n/a | 299.96M |
| 2025 FY Dec 31, 2024 | n/a | $37.28M | -$474.31M | -$206.06M | -$212.25M | n/a | n/a | n/a | -400.67% | 288.37M |
| 2025 FY Dec 31, 2023 | n/a | $52.78M | -$334.47M | -$259.17M | -$268.02M | n/a | n/a | n/a | -69.75% | 253.63M |
| 2024 FY Dec 31, 2022 | n/a | $49.04M | -$307.20M | -$263.21M | -$279.96M | n/a | n/a | n/a | -36.5% | 224.55M |
| 2023 FY Dec 31, 2021 | n/a | $58.86M | -$210.44M | -$111.18M | -$117.11M | n/a | n/a | n/a | -50.43% | 204.14M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $154.39M | sum latest 4 fiscal quarters Revenue | OK | 0001299130-26-000122, 0001299130-25-000168 |
| Revenue Growth TTM | 1.61% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001299130-26-000122, 0001299130-25-000168 |
| Revenue CAGR 3Y | -5.37% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001299130-19-000014 |
| Revenue CAGR 5Y | 22.78% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001299130-19-000014 |
| Gross Profit CAGR 3Y | n/a | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | INSUFFICIENT_HISTORY | derived |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | 0001299130-26-000122, 0001299130-25-000168 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 36.31% | Gross Profit / Revenue | OK | 0001299130-26-000122, 0001299130-25-000168 |
| Operating Margin | -88.54% | Operating Income / Revenue | OK | 0001299130-26-000122, 0001299130-25-000168 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001299130-26-000122 |
| Current Ratio | 4.92x | Current Assets / Current Liabilities | OK | derived |
| Revenue per Diluted Share | $0.50 | Revenue / Diluted Shares | OK | 0001299130-26-000122, 0001299130-25-000168 |
| SBC / FCF | n/a | SBC / FCF | NOT_MEANINGFUL | derived |
| Dividend Payout Ratio | n/a | Cash dividends paid / Net income | NOT_MEANINGFUL | derived |